Search Results - "Stern, Ralph H"

Refine Results
  1. 1

    The New Hypertension Guidelines by Stern, Ralph H

    “…The Canadian Hypertension Education Program (CHEP) has published guidelines annually since 2000. The CHEP guidelines are a model of concise, comprehensive,…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

    The role of nicotinic acid metabolites in flushing and hepatotoxicity by Stern, Ralph H., PhD, MD

    Published in Journal of clinical lipidology (01-07-2007)
    “…Abstract Flushing and hepatotoxicity are important adverse effects of nicotinic acid. This article reviews the role of metabolism of nicotinic acid in the…”
    Get full text
    Journal Article
  9. 9

    Individual Risk by Stern, Ralph H.

    “…J Clin Hypertens (Greenwich). 2012;14:261–264. ©2012 Wiley Periodicals, Inc. Patients don’t have an “individual risk” or unique probability of an outcome…”
    Get full text
    Journal Article
  10. 10

    Erythromycin Coadministration Increases Plasma Atorvastatin Concentrations by Siedlik, Paul H., Olson, Stephen C., Yang, Bing-Bing, Stern, Ralph H.

    Published in Journal of clinical pharmacology (01-05-1999)
    “…The effect of erythromycin on the pharmacokinetics of atorvastatin, an inhibitor of HMG‐CoA reductase, was investigated in 12 healthy volunteers. Each subject…”
    Get full text
    Journal Article
  11. 11

    A human MUTYH variant linking colonic polyposis to redox degradation of the [4Fe4S]2+ cluster by McDonnell, Kevin J., Chemler, Joseph A., Bartels, Phillip L., O’Brien, Elizabeth, Marvin, Monica L., Ortega, Janice, Stern, Ralph H., Raskin, Leon, Li, Guo-Min, Sherman, David H., Barton, Jacqueline K., Gruber, Stephen B.

    Published in Nature chemistry (01-08-2018)
    “…The human DNA repair enzyme MUTYH excises mispaired adenine residues in oxidized DNA. Homozygous MUTYH mutations underlie the autosomal, recessive cancer…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16

    EFFECTS OF AVASIMIBE ON CYTOCHROME P450 2C9 EXPRESSION IN VITRO AND IN VIVO by SAHI, Jasminder, STERN, Ralph H, LECLUYSE, Edward L, MILAD, Mark A, ROSE, Kelly A, GIBSON, Gordon, XIANXIAN ZHENG, STILGENBAUER, Linda, SADAGOPAN, Nalini, JOLLEY, Summer, GILBERT, Darryl

    Published in Drug metabolism and disposition (01-12-2004)
    “…Avasimibe, an acyl-CoA:cholesterol acyltransferase inhibitor, has been previously shown to be a potent inducer of CYP3A4 and multiple drug resistance protein…”
    Get full text
    Journal Article
  17. 17

    Alternatives to the ROC Curve AUC and C-statistic for Risk Prediction Models by Stern, Ralph H

    Published 14-11-2023
    “…Assessment of risk prediction models has primarily utilized measures of discrimination, the ROC curve AUC and C-statistic. These derive from the risk…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Tolerance to nicotinic acid flushing by Stern, R H, Spence, J D, Freeman, D J, Parbtani, A

    Published in Clinical pharmacology and therapeutics (01-07-1991)
    “…The mechanism of tolerance to nicotinic acid flushing was determined in subjects during a 5-day course of treatment. Objective measures of skin blood flow were…”
    Get more information
    Journal Article
  20. 20

    Atorvastatin Coadministration May Increase Digoxin Concentrations by Inhibition of Intestinal P-Glycoprotein-Mediated Secretion by Boyd, Rebecca A., Stern, Ralph H., Stewart, Barhra H., Wu, Xiaochun, Reyner, Eric L., Zegarac, Elizabeth A., Randinitis, Edward J., Whitfield, Lloyd

    Published in Journal of clinical pharmacology (01-01-2000)
    “…The effect of atorvastatin on digoxin pharmacokinetics was assessed in 24 healthy volunteers in two studies. Subjects received 0.25 mg digoxin daily for 20…”
    Get full text
    Journal Article